Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Complicated Intra-Abdominal Infections”

73 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 73 results

Large-scale testing (Phase 3)Looking for participantsNCT07089186
What this trial is testing

Study to Assess the Efficacy and Safety of Meropenem and Pralurbactam in Carbapenem-Resistant Enterobacteriaceae Infections

Who this might be right for
Hospital-acquired Bacterial Pneumonia (HABP)Ventilator-associated Bacterial Pneumonia (VABP)Complicated Intra-abdominal Infection (cIAI)+2 more
Qilu Pharmaceutical Co., Ltd. 80
Not applicableLooking for participantsNCT07268560
What this trial is testing

Real-World Effectiveness of Aztreonam-Avibactam Against MBL-Producing CRE

Who this might be right for
Complicated Intra-Abdominal Infections, cIAIsHospital-acquired Pneumonia (HAP)Ventilator-Associated Pneumonia (VAP)
Sir Run Run Shaw Hospital 100
Large-scale testing (Phase 3)Study completedNCT03293485
What this trial is testing

Efficacy and Safety of Imipenem+Cilastatin/Relebactam (MK-7655A) in Japanese Participants With Complicated Intra-abdominal Infection or Complicated Urinary Tract Infection (MK-7655A-017)

Who this might be right for
Complicated Intra-abdominal InfectionComplicated Urinary Tract Infection
Merck Sharp & Dohme LLC 83
Testing effectiveness (Phase 2)Looking for participantsNCT05639647
What this trial is testing

Study of 2 Medicines (Aztreonam and Avibactam) Compared to Best Available Therapy for Serious Gram-negative Infections

Who this might be right for
Gram-negative Bacterial Infections
Pfizer 48
Testing effectiveness (Phase 2)Study completedNCT06086626
What this trial is testing

Assess the Safety, Tolerability, and Pharmacokinetics of Cefiderocol in Hospitalized Neonates and Infants

Who this might be right for
Gram-Negative Bacterial Infections
Shionogi 30
Large-scale testing (Phase 3)Ended earlyNCT01110382
What this trial is testing

A Safety and Tolerability Study of Doripenem Compared With Meropenem in Children Hospitalized With Complicated Intra-abdominal Infections

Who this might be right for
Abscess, Intra-AbdominalAbdominal AbscessAbdomen, Acute+7 more
Janssen Research & Development, LLC 41
Large-scale testing (Phase 3)Study completedNCT03358576
What this trial is testing

Sulopenem Versus Ertapenem for Complicated Intra-abdominal Infection (cIAI)

Who this might be right for
Intra Abdominal Infections
Iterum Therapeutics, International Limited 674
Large-scale testing (Phase 3)Study completedNCT00492726
What this trial is testing

Therapy of Complicated Intra-Abdominal Infections With Moxifloxacin or Ertapenem

Who this might be right for
Infection
Bayer 804
Not applicableStudy completedNCT03408600
What this trial is testing

Physiologic Indicators for Prognosis in Abdominal Sepsis Study

Who this might be right for
Acute PeritonitisAbdominal Sepsis
World Society of Emergency Surgery 4,000
Large-scale testing (Phase 3)Study completedNCT03830333
What this trial is testing

Ceftolozane/Tazobactam (MK-7625A) Plus Metronidazole Versus Meropenem for Participants With Complicated Intra-abdominal Infection (MK-7625A-015)

Who this might be right for
Complicated Intra-abdominal Infections
Merck Sharp & Dohme LLC 268
Testing effectiveness (Phase 2)Study completedNCT03265834
What this trial is testing

CABI: Antibiotic Duration for Complicated Intra-ABdominal Infection

Who this might be right for
Complicated Intraabdominal Infections
University of Leeds 31
Post-approval studies (Phase 4)Study completedNCT00230971
What this trial is testing

Study Comparing Tigecycline Versus Ceftriaxone Sodium Plus Metronidazole in Complicated Intra-abdominal Infection (cIAI)

Who this might be right for
AppendicitisCholecystitisDiverticulitis+3 more
Wyeth is now a wholly owned subsidiary of Pfizer 473
Testing effectiveness (Phase 2)Study completedNCT02655419
What this trial is testing

Determine the PK and Safety and Tolerability of ATM-AVI for the Treatment of cIAIs in Hospitalized Adults (REJUVENATE)

Who this might be right for
Complicated Intra-Abdominal Infections, cIAIs
Pfizer 40
Post-approval studies (Phase 4)Study completedNCT01721408
What this trial is testing

Determine The Efficacy And Safety Of Tigecycline Compared With Imipenem/Cliastatin to Treat Complicated Intra-Abdominal Infection

Who this might be right for
Intra-abdominal Infection
Pfizer 470
Testing effectiveness (Phase 2)Study completedNCT01265784
What this trial is testing

Study to Compare TP-434 and Ertapenem in Community-acquired Complicated Intra-abdominal Infections

Who this might be right for
Complicated Intra-abdominal Infection
Tetraphase Pharmaceuticals, Inc 143
Large-scale testing (Phase 3)WithdrawnNCT00914888
What this trial is testing

Study Evaluating Tigecycline Versus Ceftriaxone In Complicated Intra-Abdominal Infections & Community Acquired Pneumonia

Who this might be right for
Community Acquired Bacterial PneumoniaComplicated Intra-Abdominal Infection
Wyeth is now a wholly owned subsidiary of Pfizer
Not applicableStudy completedNCT00827541
What this trial is testing

Post-Authorization Study Evaluating Safety Of Tigecycline

Who this might be right for
Intra-Abdominal InfectionsSkin Disease, InfectiousSoft Tissues Infections
Pfizer 115
Testing effectiveness (Phase 2)Study completedNCT01506271
What this trial is testing

Study of the Safety, Tolerability, and Efficacy of Relebactam (MK-7655) + Imipenem/Cilastatin Versus Imipenem/Cilastatin Alone to Treat Complicated Intra-Abdominal Infection [cIAI] (MK-7655-004)

Who this might be right for
Intra-abdominal Infections
Merck Sharp & Dohme LLC 351
Large-scale testing (Phase 3)Study completedNCT01844856
What this trial is testing

Efficacy and Safety Study of Eravacycline Compared With Ertapenem in Complicated Intra-abdominal Infections

Who this might be right for
Complicated Intra-abdominal Infections
Tetraphase Pharmaceuticals, Inc 541
Large-scale testing (Phase 3)Study completedNCT01445678
What this trial is testing

Study Comparing the Safety and Efficacy of Intravenous CXA-201 and Intravenous Meropenem in Complicated Intraabdominal Infections

Who this might be right for
Complicated Intra-abdominal Infection
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 494
Next Page